By Tsionizm Staff | March 15, 2020
A regenerative medicine company based in Haifa, Israel, says its placenta-based cell therapy product could be used to treat hundreds of patients who are suffering from respiratory and inflammatory complications associated with the COVID-19 coronavirus.
“We will first approach COVID-19 patients through compassionate use so we can treat them immediately,” explained Yaky Yanay, president and CEO of the company that produces the cell therapy. “We will be able to support the healthcare system and be able to help maintain and contain this disease…”
MORE NEWS: Hammering Out Safety Measures: Home Depot Fortifies Defenses Against Illegal Alien Problems
To read more visit The Jerusalem Post.
- General Haftar In Libya Joins With Assad
- Why American Jews Can’t Understand The Palestinian Situation
This piece originally appeared on Tsionizm.com and is used by permission.
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of Steve Gruber.
Join the Discussion
COMMENTS POLICY: We have no tolerance for messages of violence, racism, vulgarity, obscenity or other such discourteous behavior. Thank you for contributing to a respectful and useful online dialogue.